Moon River Moly Ltd. Closes $3.6 Million LIFE Offering

Executive Summary

• Moon River Moly Ltd. closed a best‑efforts private placement, issuing 4,246,716 units at C$0.85 per unit for gross proceeds of approximately C$3.61 million.
• Units consist of one common share and half of a common‑share purchase warrant; each warrant is exercisable at C$1.15 per share until 26 Feb 2028 (not before 27 Apr 2026).
• Net proceeds will fund baseline environmental studies and engineering work to advance the Davidson molybdenum‑copper‑tungsten project, further derisk the Endako Mine, and support general working capital.

Key Details

• Units Issued: 4,246,716 units @ C$0.85 each → Gross proceeds ≈ C$3,609,709.
• Unit Composition: 1 common share + ½ warrant (each full warrant = right to purchase 1 common share at C$1.15).
• Warrant Terms: Exercisable any time until 26 Feb 2028; cannot be exercised before 27 Apr 2026.
• Exemptions Used: Listed issuer financing exemption (NI 45‑106) in Canada (excluding Québec) and applicable offshore exemptions; no prospectus required.
• Statutory Hold Period: Units issued under the LIFE exemption are not subject to a statutory hold period in Canada.
• Agency Agreement: Lead Agent – Canaccord Genuity Corp.; Co‑Agent – ATB Cormark Capital Markets (dated 26 Feb 2026).
• Commission & Broker Warrants: Cash commission of ≈ C$252,670 paid to agents; issuance of 297,270 non‑transferable broker warrants (each exercisable for one unit at C$0.85) with a four‑month‑plus statutory hold expiring 27 Jun 2026.
• Related Party Participation: Directors and officers subscribed for 1,272,416 units; transaction qualifies as a related‑party transaction under MI 61‑101 but is exempt from valuation/minority approval requirements (≤25% of market cap).
• Use of Proceeds:
• Baseline environmental studies & further engineering to advance/derisk the Davidson project (near Smithers, BC) per updated PEA (23 Dec 2025).
• Additional studies to derisk and advance the Endako Mine (central BC).
• General working capital and corporate purposes.
• Regulatory Notes: Offering remains subject to final acceptance by the TSX Venture Exchange; securities not registered under U.S. securities laws and may not be offered/sold in the United States absent exemption.

Notable Quotes

(No direct quotes were provided in the release.)